De Burlo Group Inc Sanofi Transaction History

De Burlo Group Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$45.46 - $50.51 $1.17 Million - $1.3 Million	-25,800 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$45.3 - $51.62 $31,709 - $36,134	-700 Reduced 2.64%	25,800 $1.25 Million
Q3 2020 Nov 05, 2020	BUY	$49.47 - $53.77 $1.31 Million - $1.42 Million	26,500 New	26,500 $1.33 Million

795

252M

2.6M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $144B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

Stay updated on De Burlo Group Inc with notifications on news.